• No results found

T cell immunity to islets of Langerhans : relevance for immunotherapy and transplantation to cure type 1 diabetes

N/A
N/A
Protected

Academic year: 2021

Share "T cell immunity to islets of Langerhans : relevance for immunotherapy and transplantation to cure type 1 diabetes"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

T cell immunity to islets of Langerhans :

relevance for immunotherapy and transplantation to cure type 1 diabetes

Huurman, V.A.L.

Citation

Huurman, V. A. L. (2009, March 4). T cell immunity to islets of Langerhans : relevance for immunotherapy and transplantation to cure type 1 diabetes. Retrieved from

https://hdl.handle.net/1887/13597

Version: Corrected Publisher’s Version License:

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/13597 Note: To cite this publication please use the final published version (if applicable).

(2)

Stellingen

Behorende bij het proefschrift ‘T cell immunity to islets of Langerhans: relevance for immunotherapy and transplantation to cure type 1 diabetes’

1. Any possible new treatment for type 1 diabetes will have to fulfil a number of criteria: it must be easily available, safe, (cost-) effective and ultimately less of a burden than insulin treatment. (this thesis)

2. For a majority of type 1 diabetes patients, the current treatment regimens with insulin injection are appropriate and successful. (this thesis)

3. Pancreas transplantation has been widely regarded as the most effective way to achieve euglycemia in patients with type 1 diabetes and end-stage renal disease. (Burke et al., Transplantation 77(9 Suppl):S62-7)

4. Transplantation of islets of Langerhans isolated from a donor pancreas is an elegant and minimally invasive treatment for patients with type 1 diabetes suffering from poor glycemic control. (this thesis)

5. Only when autoimmune T cells can be satisfactorily countered, a definitive cure for type 1 diabetes comes in sight. (this thesis)

6. The combination of sufficiently large β-cell mass and a non-autoreactive recipient currently appears the most desirable condition to perform successful islet transplantation. (this thesis)

7. Tolerance is not only hard to achieve, but also hard to define. (this thesis) 8. Size matters. (this thesis)

9. Immune reactivity after islet transplantation has much in common with man: it proves more difficult to suppress long-lasting standard reactions than to learn to cope with something new.

10. While the achievement of tolerance comes closer in type 1 diabetes and transplantation, it seems further away than ever in everyday life.

11. Tussen droom en daad staan wetten in de weg, en praktische bezwaren.

(W. Elsschot)

12. Ask not what you can do for your thesis; ask what your thesis can do for you.

(after John F. Kennedy)

Referenties

GERELATEERDE DOCUMENTEN

In patients with type 1 diabetes, the main focus of this thesis, the disease is caused by an absolute deficiency in insulin production, most often caused by the autoimmune

(A–C) Histograms of rat splenocytes stained with 242B58 monoclonal antibody (mAb). CHO cells that express rat CTLA4 were made by anchoring the extracellular domain of CTLA4 by

The second important conclusion from our data is that the known inhibitory fusion pro- teins CTLA4Ig and LEA29Y were able to bind to APCs and to inhibit primary alloreactive

In patients responding prior to the trial, two types of proliferative reactivity patterns could be identified: a decrease in proliferative response to the peptide after initiation

Ad- ditionally, patients with pre-existent islet autoimmunity reached insulin independence less frequently when they had received less than the median of β-cell mass compared to those

Patients that did not become insulin-independent PT had significantly higher base-line total lymphocyte counts (p=0.007), T-lymphocyte counts (p=0.049), B-lymphocyte counts

FIGURE 5 Percentage of islet donors causing high CTLp reactivity in the first 26 weeks after islet transplantation, stratified for patients who were (n=15) or were not

GRAFT-SPECIFIC CYTOKINE PRODUCTION BEFORE AND AFTER TRANSPLANTATION Because cytokine production in MLC is a reflection of allograft-specific T-cell responses, quantitative differences